Symbol:
Fbxo32
Name:
F-box protein 32
RGD ID:
620373
Description:
Predicted to enable ubiquitin-protein transferase activity. Involved in muscle atrophy; positive regulation of cardiac muscle cell apoptotic process; and regulation of muscle adaptation. Predicted to be located in Z disc; cytosol; and nucleoplasm. Predicted to be part of SCF ubiquitin ligase complex. Predicted to be active in cytoplasm and nucleus. Used to study muscular atrophy. Orthologous to human FBXO32 (F-box protein 32); INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; 3,3',4,4',5-pentachlorobiphenyl.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
atrogin-1; Atrogin1; atrophy gene 1; F-box only protein 32; MAFbx; muscle atrophy F-box protein
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
FBXO32 (F-box protein 32) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, Panther
Mus musculus (house mouse):
Fbxo32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Fbxo32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
FBXO32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
FBXO32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Fbxo32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
FBXO32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
FBXO32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Fbxo32 (F-box protein 32) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Other homologs 2
Homo sapiens (human):
WDR11 (WD repeat domain 11) HGNC
OMA
Alliance orthologs 3
Homo sapiens (human):
FBXO32 (F-box protein 32)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Mus musculus (house mouse):
Fbxo32 (F-box protein 32)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
fbxo32 (F-box protein 32)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG11658
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
mfb-1
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
fbxo32
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 91,620,925 - 91,654,491 (-) NCBI GRCr8 mRatBN7.2 7 89,731,428 - 89,764,997 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 89,730,232 - 89,765,436 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 91,607,526 - 91,640,897 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 93,808,794 - 93,842,166 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 93,639,384 - 93,672,680 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 98,065,664 - 98,098,071 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 98,063,735 - 98,098,268 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 98,669,144 - 98,701,551 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 94,909,568 - 94,942,444 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 94,943,797 - 94,976,674 (-) NCBI Celera 7 86,503,248 - 86,536,357 (-) NCBI Celera Cytogenetic Map 7 q33 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Fbxo32 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO32 mRNA] CTD PMID:31150632 Fbxo32 Rat (S)-(-)-perillyl alcohol increases expression ISO RGD:737552 6480464 perillyl alcohol results in increased expression of FBXO32 mRNA; perillyl alcohol results in increased expression more ... CTD PMID:19406843 Fbxo32 Rat 1,2-dichloroethane decreases expression ISO RGD:737552 6480464 ethylene dichloride results in decreased expression of FBXO32 mRNA CTD PMID:28960355 Fbxo32 Rat 1,2-dimethylhydrazine decreases expression ISO RGD:737552 6480464 1,2-Dimethylhydrazine results in decreased expression of FBXO32 mRNA CTD PMID:22206623 Fbxo32 Rat 17beta-estradiol increases expression ISO RGD:734419 6480464 Estradiol results in increased expression of FBXO32 mRNA CTD PMID:16474171 Fbxo32 Rat 17beta-estradiol decreases expression ISO RGD:734419 6480464 Estradiol results in decreased expression of FBXO32 mRNA CTD PMID:24758408|PMID:31614463 Fbxo32 Rat 17beta-estradiol multiple interactions ISO RGD:734419 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of more ... CTD PMID:23275455|PMID:24758408 Fbxo32 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:734419 6480464 Tetrachlorodibenzodioxin results in decreased expression of FBXO32 mRNA CTD PMID:20106945 Fbxo32 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:33387578|PMID:34747641 Fbxo32 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:734419 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:30096437 Fbxo32 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737552 6480464 Tetrachlorodibenzodioxin affects the expression of FBXO32 mRNA CTD PMID:21570461 Fbxo32 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737552 6480464 Tetrachlorodibenzodioxin results in increased expression of FBXO32 mRNA CTD PMID:19933214 Fbxo32 Rat 2-butoxyethanol decreases expression ISO RGD:737552 6480464 n-butoxyethanol results in decreased expression of FBXO32 mRNA CTD PMID:19812364 Fbxo32 Rat 2-hydroxypropanoic acid decreases expression ISO RGD:734419 6480464 Lactic Acid results in decreased expression of FBXO32 mRNA CTD PMID:30851411 Fbxo32 Rat 2-trans,6-trans,10-trans-geranylgeranyl diphosphate multiple interactions ISO RGD:737552 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA]; geranylgeranyl pyrophosphate more ... CTD PMID:19406843 Fbxo32 Rat 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of FBXO32 mRNA CTD PMID:23196670 Fbxo32 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:737552 6480464 tetrabromobisphenol A results in decreased expression of FBXO32 mRNA CTD PMID:25172293 Fbxo32 Rat 3,4-methylenedioxymethamphetamine increases expression ISO RGD:737552 6480464 N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of FBXO32 mRNA CTD PMID:20188158 Fbxo32 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of FBXO32 mRNA CTD PMID:28522335 Fbxo32 Rat 3-hydroxyisovaleric acid increases expression EXP 6480464 beta-hydroxyisovaleric acid results in increased expression of FBXO32 mRNA CTD PMID:24124592 Fbxo32 Rat 3-hydroxyisovaleric acid multiple interactions EXP 6480464 beta-hydroxyisovaleric acid inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:24124592 Fbxo32 Rat 4,4'-diaminodiphenylmethane decreases expression ISO RGD:737552 6480464 4,4'-diaminodiphenylmethane results in decreased expression of FBXO32 mRNA CTD PMID:18648102 Fbxo32 Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:737552 6480464 bisphenol S results in increased expression of FBXO32 mRNA CTD PMID:30951980 Fbxo32 Rat 4,4'-sulfonyldiphenol decreases expression ISO RGD:737552 6480464 bisphenol S results in decreased expression of FBXO32 mRNA CTD PMID:39298647 Fbxo32 Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:737552 6480464 Fenretinide results in increased expression of FBXO32 mRNA CTD PMID:28973697 Fbxo32 Rat 4-nitrophenol decreases expression ISO RGD:737552 6480464 4-nitrophenol results in decreased expression of FBXO32 mRNA CTD PMID:34673133 Fbxo32 Rat 4-phenylbutyric acid multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] CTD PMID:30980806 Fbxo32 Rat 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO RGD:734419 6480464 [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 more ... CTD PMID:22146233 Fbxo32 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of FBXO32 mRNA CTD PMID:24780913 Fbxo32 Rat 6alpha-methylprednisolone increases expression EXP 6480464 Methylprednisolone results in increased expression of FBXO32 protein CTD PMID:21931329 Fbxo32 Rat 6alpha-methylprednisolone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Methylprednisolone results in increased expression of FBXO32 protein] CTD PMID:21931329 Fbxo32 Rat 8-Br-cAMP multiple interactions ISO RGD:734419 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of more ... CTD PMID:23275455 Fbxo32 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of FBXO32 mRNA CTD PMID:31881176 Fbxo32 Rat aflatoxin B1 decreases expression ISO RGD:734419 6480464 Aflatoxin B1 results in decreased expression of FBXO32 mRNA CTD PMID:22100608 Fbxo32 Rat aflatoxin B1 increases methylation ISO RGD:734419 6480464 Aflatoxin B1 results in increased methylation of FBXO32 gene CTD PMID:27153756 Fbxo32 Rat aldehydo-D-glucose multiple interactions ISO RGD:737552 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 Fbxo32 Rat aldehydo-D-glucose increases expression ISO RGD:737552 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 Fbxo32 Rat all-trans-retinoic acid multiple interactions ISO RGD:737552 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FBXO32 mRNA CTD PMID:36189433 Fbxo32 Rat alpha-Zearalanol multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of FBXO32 mRNA CTD PMID:35163327 Fbxo32 Rat amiodarone increases expression ISO RGD:734419 6480464 Amiodarone results in increased expression of FBXO32 mRNA CTD PMID:19774075 Fbxo32 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FBXO32 mRNA CTD PMID:16483693 Fbxo32 Rat amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of FBXO32 mRNA CTD PMID:30779732 Fbxo32 Rat anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:737552 6480464 pyrazolanthrone inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 Fbxo32 Rat aristolochic acid A increases expression ISO RGD:734419 6480464 aristolochic acid I results in increased expression of FBXO32 mRNA CTD PMID:33212167 Fbxo32 Rat arotinoid acid multiple interactions ISO RGD:734419 6480464 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... CTD PMID:34480604 Fbxo32 Rat arsane affects expression ISO RGD:734419 6480464 Arsenic affects the expression of FBXO32 mRNA CTD PMID:18414638 Fbxo32 Rat arsane multiple interactions ISO RGD:734419 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 more ... CTD PMID:32525701 Fbxo32 Rat arsane affects methylation ISO RGD:734419 6480464 Arsenic affects the methylation of FBXO32 gene CTD PMID:25304211 Fbxo32 Rat arsenic atom affects expression ISO RGD:734419 6480464 Arsenic affects the expression of FBXO32 mRNA CTD PMID:18414638 Fbxo32 Rat arsenic atom multiple interactions ISO RGD:734419 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 more ... CTD PMID:32525701 Fbxo32 Rat arsenic atom affects methylation ISO RGD:734419 6480464 Arsenic affects the methylation of FBXO32 gene CTD PMID:25304211 Fbxo32 Rat arsenous acid increases expression ISO RGD:737552 6480464 Arsenic Trioxide results in increased expression of FBXO32 protein CTD PMID:32184170|PMID:32635466 Fbxo32 Rat arsenous acid increases expression ISO RGD:734419 6480464 Arsenic Trioxide results in increased expression of FBXO32 mRNA CTD PMID:24356939 Fbxo32 Rat atorvastatin calcium increases expression EXP 6480464 Atorvastatin results in increased expression of FBXO32 mRNA CTD PMID:27377005 Fbxo32 Rat avobenzone increases expression ISO RGD:734419 6480464 avobenzone results in increased expression of FBXO32 mRNA CTD PMID:31016361 Fbxo32 Rat benzo[a]pyrene decreases expression ISO RGD:734419 6480464 Benzo(a)pyrene results in decreased expression of FBXO32 mRNA CTD PMID:20106945 Fbxo32 Rat benzo[a]pyrene decreases methylation ISO RGD:734419 6480464 Benzo(a)pyrene results in decreased methylation of FBXO32 5' UTR CTD PMID:27901495 Fbxo32 Rat benzo[a]pyrene increases methylation ISO RGD:734419 6480464 Benzo(a)pyrene results in increased methylation of FBXO32 3' UTR; Benzo(a)pyrene results in increased methylation of more ... CTD PMID:27901495 Fbxo32 Rat benzo[a]pyrene decreases expression ISO RGD:737552 6480464 Benzo(a)pyrene results in decreased expression of FBXO32 mRNA CTD PMID:22228805 Fbxo32 Rat benzo[a]pyrene increases expression ISO RGD:737552 6480464 Benzo(a)pyrene results in increased expression of FBXO32 mRNA CTD PMID:21715664 Fbxo32 Rat bis(2-chloroethyl) sulfide increases expression ISO RGD:734419 6480464 Mustard Gas results in increased expression of FBXO32 mRNA CTD PMID:25102026 Fbxo32 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:734419 6480464 [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of FBXO32 more ... CTD PMID:33872906 Fbxo32 Rat bisphenol A increases expression ISO RGD:737552 6480464 bisphenol A results in increased expression of FBXO32 mRNA CTD PMID:26063408 Fbxo32 Rat bisphenol A multiple interactions ISO RGD:734419 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO32 gene CTD PMID:31601247 Fbxo32 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of FBXO32 mRNA CTD PMID:30816183|PMID:32528016 Fbxo32 Rat bisphenol A increases expression ISO RGD:734419 6480464 bisphenol A results in increased expression of FBXO32 mRNA CTD PMID:16474171|PMID:25047013|PMID:29275510 Fbxo32 Rat bisphenol F increases expression ISO RGD:737552 6480464 bisphenol F results in increased expression of FBXO32 mRNA CTD PMID:38685157 Fbxo32 Rat Botulinum toxin type A multiple interactions ISO RGD:737552 6480464 Ouabain affects the reaction [Botulinum Toxins, Type A affects the expression of FBXO32 mRNA] CTD PMID:21139329 Fbxo32 Rat Botulinum toxin type A affects expression ISO RGD:737552 6480464 Botulinum Toxins, Type A affects the expression of FBXO32 mRNA CTD PMID:21139329 Fbxo32 Rat cadmium atom multiple interactions ISO RGD:737552 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXO32 more ... CTD PMID:37325564 Fbxo32 Rat cadmium dichloride multiple interactions ISO RGD:737552 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of FBXO32 more ... CTD PMID:37325564 Fbxo32 Rat calcitriol decreases expression ISO RGD:734419 6480464 Calcitriol results in decreased expression of FBXO32 mRNA CTD PMID:16002434 Fbxo32 Rat calcitriol multiple interactions ISO RGD:737552 6480464 Calcitriol inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:29962435 Fbxo32 Rat cannabidiol increases expression ISO RGD:734419 6480464 Cannabidiol results in increased expression of FBXO32 mRNA CTD PMID:26504004 Fbxo32 Rat cannabidiol multiple interactions ISO RGD:734419 6480464 [Dronabinol co-treated with Cannabidiol] results in increased expression of FBXO32 mRNA CTD PMID:26504004 Fbxo32 Rat cantharidin decreases expression ISO RGD:737552 6480464 Cantharidin results in decreased expression of FBXO32 mRNA CTD PMID:36907384 Fbxo32 Rat carbon nanotube affects expression ISO RGD:737552 6480464 Nanotubes, Carbon analog affects the expression of FBXO32 mRNA CTD PMID:25554681 Fbxo32 Rat carbon nanotube decreases expression ISO RGD:737552 6480464 Nanotubes, Carbon results in decreased expression of FBXO32 mRNA CTD PMID:25554681 Fbxo32 Rat carmustine affects response to substance ISO RGD:734419 6480464 FBXO32 mRNA affects the susceptibility to Carmustine CTD PMID:16365179 Fbxo32 Rat celastrol decreases expression EXP 6480464 celastrol results in decreased expression of FBXO32 protein CTD PMID:25903958 Fbxo32 Rat celastrol multiple interactions EXP 6480464 HSPA1A protein affects the reaction [celastrol results in decreased expression of FBXO32 protein] CTD PMID:25903958 Fbxo32 Rat CGP 52608 multiple interactions ISO RGD:734419 6480464 CGP 52608 promotes the reaction [RORA protein binds to FBXO32 gene] CTD PMID:28238834 Fbxo32 Rat CHIR 99021 decreases expression ISO RGD:737552 6480464 Chir 99021 results in decreased expression of FBXO32 mRNA CTD PMID:21832246 Fbxo32 Rat CHIR 99021 multiple interactions ISO RGD:734419 6480464 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... CTD PMID:34480604 Fbxo32 Rat CHIR 99021 multiple interactions ISO RGD:737552 6480464 Chir 99021 inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA] CTD PMID:21832246 Fbxo32 Rat chlordecone increases expression ISO RGD:737552 6480464 Chlordecone results in increased expression of FBXO32 mRNA CTD PMID:33711761 Fbxo32 Rat chloroquine affects expression EXP 6480464 Chloroquine affects the expression of FBXO32 mRNA CTD PMID:19296457 Fbxo32 Rat chlorpyrifos decreases expression ISO RGD:737552 6480464 Chlorpyrifos results in decreased expression of FBXO32 mRNA CTD PMID:37019170 Fbxo32 Rat choline multiple interactions ISO RGD:737552 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Fbxo32 Rat chromium atom decreases expression EXP 6480464 Chromium deficiency results in decreased expression of FBXO32 mRNA; Chromium results in decreased expression of more ... CTD PMID:19071005|PMID:20404053 Fbxo32 Rat chromium(6+) multiple interactions ISO RGD:734419 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in increased expression more ... CTD PMID:38479592 Fbxo32 Rat cisplatin increases expression ISO RGD:737552 6480464 Cisplatin results in increased expression of FBXO32; Cisplatin results in increased expression of FBXO32 mRNA CTD PMID:21074548|PMID:24823295|PMID:32738330 Fbxo32 Rat cobalt dichloride increases expression ISO RGD:737552 6480464 cobaltous chloride results in increased expression of FBXO32 protein CTD PMID:23684559 Fbxo32 Rat copper(II) chloride decreases expression ISO RGD:734419 6480464 cupric chloride results in decreased expression of FBXO32 mRNA CTD PMID:38568856 Fbxo32 Rat copper(II) sulfate increases expression ISO RGD:734419 6480464 Copper Sulfate results in increased expression of FBXO32 mRNA CTD PMID:19549813 Fbxo32 Rat cortisol multiple interactions ISO RGD:734419 6480464 [4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid co-treated with Chir 99021 co-treated with 3-(4-pyridyl)-1H-indole co-treated with Hydrocortisone co-treated with EGF more ... CTD PMID:34480604 Fbxo32 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of FBXO32 mRNA CTD PMID:27523638 Fbxo32 Rat cyclosporin A increases expression ISO RGD:734419 6480464 Cyclosporine results in increased expression of FBXO32 mRNA CTD PMID:25562108|PMID:27989131 Fbxo32 Rat D-glucose increases expression ISO RGD:737552 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 Fbxo32 Rat D-glucose multiple interactions ISO RGD:737552 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 Fbxo32 Rat DDE decreases expression ISO RGD:734419 6480464 Dichlorodiphenyl Dichloroethylene results in decreased expression of FBXO32 mRNA CTD PMID:38568856 Fbxo32 Rat DDT decreases expression EXP 6480464 DDT results in decreased expression of FBXO32 mRNA CTD PMID:30207508 Fbxo32 Rat dexamethasone multiple interactions ISO RGD:737552 6480464 (+)-JQ1 compound inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA]; Calcitriol inhibits more ... CTD PMID:19032942|PMID:21832246|PMID:22733784|PMID:23752591|PMID:29962435|PMID:31706954 Fbxo32 Rat dexamethasone increases expression ISO RGD:737552 6480464 Dexamethasone results in increased expression of FBXO32 mRNA; Dexamethasone results in increased expression of FBXO32 more ... CTD PMID:19032942|PMID:19262011|PMID:21832246|PMID:22733784|PMID:23752591|PMID:29962435|PMID:31706954 Fbxo32 Rat dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of FBXO32 mRNA CTD PMID:18436443|PMID:24124592 Fbxo32 Rat dexamethasone multiple interactions EXP 6480464 beta-hydroxyisovaleric acid inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA]; Testosterone inhibits more ... CTD PMID:18436443|PMID:24124592 Fbxo32 Rat diarsenic trioxide increases expression ISO RGD:737552 6480464 Arsenic Trioxide results in increased expression of FBXO32 protein CTD PMID:32184170|PMID:32635466 Fbxo32 Rat diarsenic trioxide increases expression ISO RGD:734419 6480464 Arsenic Trioxide results in increased expression of FBXO32 mRNA CTD PMID:24356939 Fbxo32 Rat diazinon increases methylation ISO RGD:734419 6480464 Diazinon results in increased methylation of FBXO32 gene CTD PMID:22964155 Fbxo32 Rat dibutyl phthalate decreases expression ISO RGD:737552 6480464 Dibutyl Phthalate results in decreased expression of FBXO32 mRNA CTD PMID:21266533 Fbxo32 Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of FBXO32 mRNA CTD PMID:21266533 Fbxo32 Rat dioxygen increases expression ISO RGD:737552 6480464 Oxygen deficiency results in increased expression of FBXO32 mRNA CTD PMID:23624791 Fbxo32 Rat dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression more ... CTD PMID:33729688 Fbxo32 Rat dioxygen multiple interactions ISO RGD:737552 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO32 mRNA CTD PMID:30529165 Fbxo32 Rat dioxygen increases expression ISO RGD:734419 6480464 Oxygen deficiency results in increased expression of FBXO32 mRNA CTD PMID:26516004 Fbxo32 Rat disodium selenite increases expression ISO RGD:734419 6480464 Sodium Selenite results in increased expression of FBXO32 mRNA CTD PMID:18175754|PMID:24383545 Fbxo32 Rat doxorubicin multiple interactions EXP 6480464 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Doxorubicin results in increased expression of FBXO32 mRNA]; AKT1 protein inhibits more ... CTD PMID:18346979 Fbxo32 Rat doxorubicin increases expression ISO RGD:734419 6480464 Doxorubicin results in increased expression of FBXO32 mRNA CTD PMID:29803840 Fbxo32 Rat doxorubicin affects expression ISO RGD:734419 6480464 Doxorubicin affects the expression of FBXO32 mRNA CTD PMID:25529476 Fbxo32 Rat doxorubicin increases expression ISO RGD:737552 6480464 Doxorubicin results in increased expression of FBXO32 mRNA; Doxorubicin results in increased expression of FBXO32 more ... CTD PMID:23639627|PMID:25896364 Fbxo32 Rat doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of FBXO32 mRNA; Doxorubicin results in increased expression of FBXO32 more ... CTD PMID:18346979|PMID:23639627 Fbxo32 Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of FBXO32 mRNA CTD PMID:29391264 Fbxo32 Rat ethanol affects splicing ISO RGD:737552 6480464 Ethanol affects the splicing of FBXO32 mRNA CTD PMID:30319688 Fbxo32 Rat fenofibrate multiple interactions ISO RGD:737552 6480464 Lovastatin promotes the reaction [Fenofibrate results in increased expression of FBXO32 protein]; PPARA protein affects more ... CTD PMID:33408297 Fbxo32 Rat fenofibrate increases expression ISO RGD:737552 6480464 Fenofibrate results in increased expression of FBXO32 mRNA; Fenofibrate results in increased expression of FBXO32 more ... CTD PMID:33408297 Fbxo32 Rat fluoranthene multiple interactions ISO RGD:737552 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of FBXO32 mRNA CTD PMID:28329830 Fbxo32 Rat folic acid multiple interactions ISO RGD:737552 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Fbxo32 Rat fulvestrant multiple interactions ISO RGD:734419 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of FBXO32 gene CTD PMID:31601247 Fbxo32 Rat gamma-hexachlorocyclohexane increases expression ISO RGD:734419 6480464 Hexachlorocyclohexane results in increased expression of FBXO32 mRNA CTD PMID:24356939 Fbxo32 Rat genistein increases expression ISO RGD:734419 6480464 Genistein results in increased expression of FBXO32 mRNA CTD PMID:16474171 Fbxo32 Rat glucose multiple interactions ISO RGD:737552 6480464 FBXO32 protein affects the reaction [Glucose results in decreased expression of KCNN2 protein] CTD PMID:30635400 Fbxo32 Rat glucose increases expression ISO RGD:737552 6480464 Glucose results in increased expression of FBXO32 protein CTD PMID:30635400 Fbxo32 Rat GSK-J4 increases expression ISO RGD:734419 6480464 GSK-J4 results in increased expression of FBXO32 mRNA CTD PMID:29301935 Fbxo32 Rat hexadecanoic acid increases expression ISO RGD:737552 6480464 Palmitic Acid results in increased expression of FBXO32 mRNA CTD PMID:25614714 Fbxo32 Rat hexadecanoic acid multiple interactions ISO RGD:737552 6480464 Quercetin inhibits the reaction [Palmitic Acid results in increased expression of FBXO32 mRNA] CTD PMID:25614714 Fbxo32 Rat indoxyl sulfate multiple interactions ISO RGD:737552 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein]; pyrazolanthrone inhibits the more ... CTD PMID:30849338 Fbxo32 Rat indoxyl sulfate increases expression ISO RGD:737552 6480464 Indican results in increased expression of FBXO32 mRNA; Indican results in increased expression of FBXO32 more ... CTD PMID:29380555|PMID:30849338 Fbxo32 Rat isoprenaline increases expression ISO RGD:737552 6480464 Isoproterenol results in increased expression of FBXO32 mRNA CTD PMID:20003209 Fbxo32 Rat L-ascorbic acid multiple interactions ISO RGD:734419 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with more ... CTD PMID:34480604 Fbxo32 Rat L-ascorbic acid 2-phosphate multiple interactions ISO RGD:734419 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA more ... CTD PMID:34480604 Fbxo32 Rat L-methionine multiple interactions ISO RGD:737552 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... CTD PMID:20938992 Fbxo32 Rat lead diacetate increases expression ISO RGD:737552 6480464 lead acetate results in increased expression of FBXO32 mRNA CTD PMID:20542052 Fbxo32 Rat Licochalcone B increases expression ISO RGD:734419 6480464 licochalcone B results in increased expression of FBXO32 mRNA CTD PMID:33647349 Fbxo32 Rat lipopolysaccharide increases expression ISO RGD:737552 6480464 Lipopolysaccharides results in increased expression of FBXO32 mRNA CTD PMID:17131360 Fbxo32 Rat lithium chloride decreases expression ISO RGD:737552 6480464 Lithium Chloride results in decreased expression of FBXO32 mRNA CTD PMID:21832246 Fbxo32 Rat lithocholic acid decreases expression ISO RGD:737552 6480464 Lithocholic Acid results in decreased expression of FBXO32 mRNA CTD PMID:39695227 Fbxo32 Rat lovastatin multiple interactions ISO RGD:737552 6480464 geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA]; geranylgeranyl pyrophosphate more ... CTD PMID:19406843|PMID:33408297 Fbxo32 Rat lovastatin increases expression ISO RGD:737552 6480464 Lovastatin results in increased expression of FBXO32 mRNA; Lovastatin results in increased expression of FBXO32 more ... CTD PMID:19406843 Fbxo32 Rat LY294002 decreases expression ISO RGD:737552 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of FBXO32 mRNA CTD PMID:21832246 Fbxo32 Rat metformin decreases expression EXP 6480464 Metformin results in decreased expression of FBXO32 mRNA CTD PMID:31324951 Fbxo32 Rat methamphetamine increases expression ISO RGD:737552 6480464 Methamphetamine results in increased expression of FBXO32 mRNA CTD PMID:23933405 Fbxo32 Rat methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of FBXO32 gene CTD PMID:35440735 Fbxo32 Rat methylmercury chloride increases expression ISO RGD:734419 6480464 methylmercuric chloride results in increased expression of FBXO32 mRNA CTD PMID:28001369 Fbxo32 Rat mevalonic acid multiple interactions ISO RGD:737552 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of FBXO32 mRNA]; Mevalonic Acid more ... CTD PMID:19406843 Fbxo32 Rat mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:734419 6480464 [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of FBXO32 more ... CTD PMID:33872906 Fbxo32 Rat mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:737552 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of FBXO32 mRNA CTD PMID:36189433 Fbxo32 Rat monocrotaline multiple interactions EXP 6480464 resveratrol inhibits the reaction [Monocrotaline results in decreased expression of FBXO32 mRNA] CTD PMID:22146233 Fbxo32 Rat monocrotaline increases expression EXP 6480464 Monocrotaline results in increased expression of FBXO32 mRNA CTD PMID:18801959 Fbxo32 Rat monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of FBXO32 mRNA CTD PMID:22146233 Fbxo32 Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of FBXO32 mRNA CTD PMID:21515302 Fbxo32 Rat N-acetyl-L-cysteine multiple interactions ISO RGD:737552 6480464 Acetylcysteine inhibits the reaction [Indican results in increased expression of FBXO32 protein] CTD PMID:30849338 Fbxo32 Rat N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:737552 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [FBXO32 protein results in decreased expression of KCNN2 protein] CTD PMID:30635400 Fbxo32 Rat nickel atom decreases expression ISO RGD:734419 6480464 Nickel results in decreased expression of FBXO32 mRNA CTD PMID:24768652 Fbxo32 Rat nickel dichloride increases expression ISO RGD:734419 6480464 nickel chloride results in increased expression of FBXO32 mRNA CTD PMID:21455298 Fbxo32 Rat nickel sulfate increases expression ISO RGD:734419 6480464 nickel sulfate results in increased expression of FBXO32 mRNA CTD PMID:22714537 Fbxo32 Rat ochratoxin A decreases expression ISO RGD:734419 6480464 ochratoxin A metabolite results in decreased expression of FBXO32 mRNA CTD PMID:24356939 Fbxo32 Rat okadaic acid decreases expression ISO RGD:734419 6480464 Okadaic Acid results in decreased expression of FBXO32 mRNA CTD PMID:38832940 Fbxo32 Rat ouabain multiple interactions ISO RGD:737552 6480464 Ouabain affects the reaction [Botulinum Toxins, Type A affects the expression of FBXO32 mRNA] CTD PMID:21139329 Fbxo32 Rat ozone multiple interactions ISO RGD:737552 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FBXO32 more ... CTD PMID:27106289 Fbxo32 Rat paraquat multiple interactions ISO RGD:737552 6480464 ST2825 inhibits the reaction [Paraquat results in increased expression of FBXO32 mRNA] CTD PMID:34811946 Fbxo32 Rat paraquat increases expression ISO RGD:737552 6480464 Paraquat results in increased expression of FBXO32 mRNA CTD PMID:34811946 Fbxo32 Rat perfluorohexanesulfonic acid decreases expression ISO RGD:734419 6480464 perfluorohexanesulfonic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 Fbxo32 Rat perfluorononanoic acid decreases expression ISO RGD:734419 6480464 perfluoro-n-nonanoic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 Fbxo32 Rat perfluorooctane-1-sulfonic acid increases expression ISO RGD:734419 6480464 perfluorooctane sulfonic acid results in increased expression of FBXO32 mRNA CTD PMID:38568856 Fbxo32 Rat perfluorooctane-1-sulfonic acid decreases expression ISO RGD:734419 6480464 perfluorooctane sulfonic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 Fbxo32 Rat perfluorooctanoic acid multiple interactions EXP 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of FBXO32 mRNA CTD PMID:35163327 Fbxo32 Rat perfluorooctanoic acid decreases expression ISO RGD:734419 6480464 perfluorooctanoic acid results in decreased expression of FBXO32 mRNA CTD PMID:25812627 Fbxo32 Rat perillyl alcohol increases expression ISO RGD:737552 6480464 perillyl alcohol results in increased expression of FBXO32 mRNA; perillyl alcohol results in increased expression more ... CTD PMID:19406843 Fbxo32 Rat phenethyl isothiocyanate increases expression ISO RGD:734419 6480464 phenethyl isothiocyanate results in increased expression of FBXO32 mRNA CTD PMID:26678675 Fbxo32 Rat phenobarbital affects expression ISO RGD:734419 6480464 Phenobarbital affects the expression of FBXO32 mRNA CTD PMID:19159669 Fbxo32 Rat potassium chromate decreases expression ISO RGD:734419 6480464 potassium chromate(VI) results in decreased expression of FBXO32 mRNA CTD PMID:22714537 Fbxo32 Rat progesterone multiple interactions ISO RGD:734419 6480464 [Progesterone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with Estradiol] results in increased expression of more ... CTD PMID:23275455 Fbxo32 Rat quercetin multiple interactions ISO RGD:737552 6480464 Quercetin inhibits the reaction [Dietary Fats results in increased expression of FBXO32 mRNA]; Quercetin inhibits more ... CTD PMID:25614714 Fbxo32 Rat rac-lactic acid decreases expression ISO RGD:734419 6480464 Lactic Acid results in decreased expression of FBXO32 mRNA CTD PMID:30851411 Fbxo32 Rat resveratrol multiple interactions EXP 6480464 [resveratrol results in increased localization of and results in increased activity of FOXO1 protein] which more ... CTD PMID:18077353|PMID:22146233 Fbxo32 Rat resveratrol multiple interactions ISO RGD:737552 6480464 FOXO1 protein promotes the reaction [resveratrol inhibits the reaction [TNF protein results in increased expression more ... CTD PMID:24534773 Fbxo32 Rat resveratrol decreases expression ISO RGD:734419 6480464 resveratrol results in decreased expression of FBXO32 mRNA CTD PMID:25888808 Fbxo32 Rat resveratrol increases expression ISO RGD:734419 6480464 resveratrol results in increased expression of FBXO32 mRNA CTD PMID:22146233 Fbxo32 Rat SB 431542 multiple interactions ISO RGD:734419 6480464 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in more ... CTD PMID:34480604 Fbxo32 Rat simvastatin increases expression ISO RGD:737552 6480464 Simvastatin results in increased expression of FBXO32 mRNA; Simvastatin results in increased expression of FBXO32 more ... CTD PMID:25300705|PMID:27734117|PMID:33034787 Fbxo32 Rat simvastatin multiple interactions ISO RGD:737552 6480464 FST protein inhibits the reaction [Simvastatin results in increased expression of FBXO32 mRNA]; FST protein more ... CTD PMID:27734117|PMID:33034787 Fbxo32 Rat simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of FBXO32 mRNA CTD PMID:19001041|PMID:25300705 Fbxo32 Rat sirolimus multiple interactions ISO RGD:734419 6480464 [(+)-JQ1 compound co-treated with Sirolimus] affects the expression of FBXO32 mRNA; Sirolimus inhibits the reaction more ... CTD PMID:21245298|PMID:25307878 Fbxo32 Rat sirolimus increases expression ISO RGD:734419 6480464 Sirolimus results in increased expression of FBXO32 mRNA CTD PMID:24356939 Fbxo32 Rat sirtinol multiple interactions ISO RGD:734419 6480464 [sirtinol results in decreased activity of SIRT1 protein] which results in decreased expression of FBXO32 more ... CTD PMID:22146233 Fbxo32 Rat sodium arsenate increases expression ISO RGD:737552 6480464 sodium arsenate results in increased expression of FBXO32 mRNA CTD PMID:21795629 Fbxo32 Rat sodium arsenate multiple interactions ISO RGD:734419 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of FBXO32 more ... CTD PMID:32525701 Fbxo32 Rat sodium arsenite increases expression ISO RGD:734419 6480464 sodium arsenite results in increased expression of FBXO32 mRNA CTD PMID:22714537|PMID:23876855 Fbxo32 Rat sodium arsenite decreases expression ISO RGD:734419 6480464 sodium arsenite results in decreased expression of FBXO32 mRNA CTD PMID:34032870 Fbxo32 Rat streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of FBXO32 protein CTD PMID:30980806 Fbxo32 Rat streptozocin increases expression ISO RGD:737552 6480464 Streptozocin results in increased expression of FBXO32 protein CTD PMID:30635400 Fbxo32 Rat streptozocin multiple interactions EXP 6480464 4-phenylbutyric acid inhibits the reaction [Streptozocin results in increased expression of FBXO32 protein] CTD PMID:30980806 Fbxo32 Rat sulforaphane decreases expression ISO RGD:734419 6480464 sulforaphane results in decreased expression of FBXO32 mRNA CTD PMID:31838189 Fbxo32 Rat sunitinib increases expression ISO RGD:737552 6480464 Sunitinib results in increased expression of FBXO32 mRNA CTD PMID:31445075 Fbxo32 Rat sunitinib increases expression ISO RGD:734419 6480464 Sunitinib results in increased expression of FBXO32 mRNA CTD PMID:31533062 Fbxo32 Rat temozolomide affects response to substance ISO RGD:734419 6480464 FBXO32 mRNA affects the susceptibility to temozolomide CTD PMID:16365179 Fbxo32 Rat temozolomide increases expression ISO RGD:734419 6480464 Temozolomide results in increased expression of FBXO32 mRNA CTD PMID:31758290 Fbxo32 Rat Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of FBXO32 mRNA CTD PMID:21515302 Fbxo32 Rat testosterone affects expression ISO RGD:737552 6480464 Testosterone affects the expression of FBXO32 mRNA CTD PMID:20403060 Fbxo32 Rat testosterone multiple interactions EXP 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA]; Testosterone inhibits the more ... CTD PMID:18436443|PMID:21931329 Fbxo32 Rat testosterone increases expression EXP 6480464 Testosterone deficiency results in increased expression of FBXO32 mRNA; Testosterone deficiency results in increased expression more ... CTD PMID:19926828 Fbxo32 Rat testosterone multiple interactions ISO RGD:737552 6480464 Testosterone inhibits the reaction [Testosterone deficiency results in increased expression of FBXO32 mRNA] CTD PMID:21045173 Fbxo32 Rat testosterone increases expression ISO RGD:737552 6480464 Testosterone deficiency results in increased expression of FBXO32 mRNA; Testosterone results in increased expression of more ... CTD PMID:20403060|PMID:21045173 Fbxo32 Rat tetrachloro-1,4-benzoquinone increases expression ISO RGD:734419 6480464 Chloranil results in increased expression of FBXO32 mRNA CTD PMID:24214992 Fbxo32 Rat tetrachloroethene increases expression ISO RGD:737552 6480464 Tetrachloroethylene results in increased expression of FBXO32 mRNA CTD PMID:28973375 Fbxo32 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of FBXO32 mRNA] CTD PMID:31150632 Fbxo32 Rat tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of FBXO32 mRNA CTD PMID:31150632 Fbxo32 Rat thapsigargin increases expression ISO RGD:734419 6480464 Thapsigargin results in increased expression of FBXO32 mRNA CTD PMID:22378314 Fbxo32 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FBXO32 mRNA CTD PMID:34492290 Fbxo32 Rat titanium dioxide increases expression ISO RGD:737552 6480464 titanium dioxide results in increased expression of FBXO32 mRNA CTD PMID:23557971 Fbxo32 Rat titanium dioxide increases methylation ISO RGD:737552 6480464 titanium dioxide results in increased methylation of FBXO32 promoter CTD PMID:35295148 Fbxo32 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FBXO32 mRNA CTD PMID:33387578 Fbxo32 Rat triphenyl phosphate affects expression ISO RGD:734419 6480464 triphenyl phosphate affects the expression of FBXO32 mRNA CTD PMID:37042841 Fbxo32 Rat troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of FBXO32 mRNA CTD PMID:21515302 Fbxo32 Rat tungsten decreases expression ISO RGD:737552 6480464 Tungsten results in decreased expression of FBXO32 mRNA CTD PMID:30912803 Fbxo32 Rat tunicamycin increases expression ISO RGD:734419 6480464 Tunicamycin results in increased expression of FBXO32 mRNA CTD PMID:22378314 Fbxo32 Rat urethane increases expression ISO RGD:734419 6480464 Urethane results in increased expression of FBXO32 mRNA CTD PMID:28818685 Fbxo32 Rat valproic acid increases expression ISO RGD:734419 6480464 Valproic Acid results in increased expression of FBXO32 mRNA CTD PMID:28001369 Fbxo32 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FBXO32 mRNA CTD PMID:23034163 Fbxo32 Rat XAV939 multiple interactions ISO RGD:734419 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA more ... CTD PMID:34480604 Fbxo32 Rat zinc atom multiple interactions ISO RGD:734419 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO32 mRNA CTD PMID:18593933 Fbxo32 Rat zinc(0) multiple interactions ISO RGD:734419 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of FBXO32 mRNA CTD PMID:18593933
(+)-schisandrin B (EXP) (S)-(-)-perillyl alcohol (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 17beta-estradiol (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-butoxyethanol (ISO) 2-hydroxypropanoic acid (ISO) 2-trans,6-trans,10-trans-geranylgeranyl diphosphate (ISO) 3,3',4,4',5-pentachlorobiphenyl (EXP) 3,3',5,5'-tetrabromobisphenol A (ISO) 3,4-methylenedioxymethamphetamine (ISO) 3-chloropropane-1,2-diol (EXP) 3-hydroxyisovaleric acid (EXP) 4,4'-diaminodiphenylmethane (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 4-nitrophenol (ISO) 4-phenylbutyric acid (EXP) 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide (ISO) 6-propyl-2-thiouracil (EXP) 6alpha-methylprednisolone (EXP) 8-Br-cAMP (ISO) acetamide (EXP) aflatoxin B1 (ISO) aldehydo-D-glucose (ISO) all-trans-retinoic acid (ISO) alpha-Zearalanol (EXP) amiodarone (ISO) ammonium chloride (EXP) amphetamine (EXP) anthra[1,9-cd]pyrazol-6(2H)-one (ISO) aristolochic acid A (ISO) arotinoid acid (ISO) arsane (ISO) arsenic atom (ISO) arsenous acid (ISO) atorvastatin calcium (EXP) avobenzone (ISO) benzo[a]pyrene (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) bisphenol F (ISO) Botulinum toxin type A (ISO) cadmium atom (ISO) cadmium dichloride (ISO) calcitriol (ISO) cannabidiol (ISO) cantharidin (ISO) carbon nanotube (ISO) carmustine (ISO) celastrol (EXP) CGP 52608 (ISO) CHIR 99021 (ISO) chlordecone (ISO) chloroquine (EXP) chlorpyrifos (ISO) choline (ISO) chromium atom (EXP) chromium(6+) (ISO) cisplatin (ISO) cobalt dichloride (ISO) copper(II) chloride (ISO) copper(II) sulfate (ISO) cortisol (ISO) Cuprizon (EXP) cyclosporin A (ISO) D-glucose (ISO) DDE (ISO) DDT (EXP) dexamethasone (EXP,ISO) diarsenic trioxide (ISO) diazinon (ISO) dibutyl phthalate (EXP,ISO) dioxygen (EXP,ISO) disodium selenite (ISO) doxorubicin (EXP,ISO) endosulfan (EXP) ethanol (ISO) fenofibrate (ISO) fluoranthene (ISO) folic acid (ISO) fulvestrant (ISO) gamma-hexachlorocyclohexane (ISO) genistein (ISO) glucose (ISO) GSK-J4 (ISO) hexadecanoic acid (ISO) indoxyl sulfate (ISO) isoprenaline (ISO) L-ascorbic acid (ISO) L-ascorbic acid 2-phosphate (ISO) L-methionine (ISO) lead diacetate (ISO) Licochalcone B (ISO) lipopolysaccharide (ISO) lithium chloride (ISO) lithocholic acid (ISO) lovastatin (ISO) LY294002 (ISO) metformin (EXP) methamphetamine (ISO) methoxychlor (EXP) methylmercury chloride (ISO) mevalonic acid (ISO) mono(2-ethylhexyl) phthalate (ISO) monocrotaline (EXP) Muraglitazar (EXP) N-acetyl-L-cysteine (ISO) N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal (ISO) nickel atom (ISO) nickel dichloride (ISO) nickel sulfate (ISO) ochratoxin A (ISO) okadaic acid (ISO) ouabain (ISO) ozone (ISO) paraquat (ISO) perfluorohexanesulfonic acid (ISO) perfluorononanoic acid (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (EXP,ISO) perillyl alcohol (ISO) phenethyl isothiocyanate (ISO) phenobarbital (ISO) potassium chromate (ISO) progesterone (ISO) quercetin (ISO) rac-lactic acid (ISO) resveratrol (EXP,ISO) SB 431542 (ISO) simvastatin (EXP,ISO) sirolimus (ISO) sirtinol (ISO) sodium arsenate (ISO) sodium arsenite (ISO) streptozocin (EXP,ISO) sulforaphane (ISO) sunitinib (ISO) temozolomide (ISO) Tesaglitazar (EXP) testosterone (EXP,ISO) tetrachloro-1,4-benzoquinone (ISO) tetrachloroethene (ISO) tetrachloromethane (EXP) thapsigargin (ISO) thioacetamide (EXP) titanium dioxide (ISO) trichloroethene (EXP) triphenyl phosphate (ISO) troglitazone (EXP) tungsten (ISO) tunicamycin (ISO) urethane (ISO) valproic acid (ISO) vinclozolin (EXP) XAV939 (ISO) zinc atom (ISO) zinc(0) (ISO)
1.
Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.
Batt J, etal., Am J Respir Cell Mol Biol. 2014 Jan;50(1):74-86. doi: 10.1165/rcmb.2012-0506OC.
2.
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine SC, etal., Science 2001 Nov 23;294(5547):1704-8.
3.
Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection.
Dehoux MJ, etal., FEBS Lett 2003 Jun 5;544(1-3):214-7.
4.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
5.
Myogenin regulates denervation-dependent muscle atrophy in mouse soleus muscle.
Macpherson PC, etal., J Cell Biochem. 2011 Aug;112(8):2149-59. doi: 10.1002/jcb.23136.
6.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
7.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
8.
GOA pipeline
RGD automated data pipeline
9.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
10.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
11.
The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1.
Song DW, etal., Biochem J. 2014 Jan 1;457(1):151-62. doi: 10.1042/BJ20130833.
Fbxo32 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 7 91,620,925 - 91,654,491 (-) NCBI GRCr8 mRatBN7.2 7 89,731,428 - 89,764,997 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 7 89,730,232 - 89,765,436 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 7 91,607,526 - 91,640,897 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 7 93,808,794 - 93,842,166 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 7 93,639,384 - 93,672,680 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 7 98,065,664 - 98,098,071 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 7 98,063,735 - 98,098,268 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 7 98,669,144 - 98,701,551 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 7 94,909,568 - 94,942,444 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 7 94,943,797 - 94,976,674 (-) NCBI Celera 7 86,503,248 - 86,536,357 (-) NCBI Celera Cytogenetic Map 7 q33 NCBI
FBXO32 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 8 123,497,889 - 123,541,206 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 8 123,497,889 - 123,541,206 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 8 124,510,129 - 124,553,446 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 8 124,584,539 - 124,622,627 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 8 124,584,539 - 124,613,564 NCBI Celera 8 120,703,016 - 120,741,104 (-) NCBI Celera Cytogenetic Map 8 q24.13 NCBI HuRef 8 119,835,717 - 119,879,094 (-) NCBI HuRef CHM1_1 8 124,550,510 - 124,593,876 (-) NCBI CHM1_1 T2T-CHM13v2.0 8 124,628,980 - 124,672,309 (-) NCBI T2T-CHM13v2.0
Fbxo32 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 15 58,039,275 - 58,078,288 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 15 58,039,275 - 58,078,328 (-) Ensembl GRCm39 Ensembl GRCm38 15 58,175,879 - 58,214,892 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 15 58,175,879 - 58,214,932 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 15 58,011,634 - 58,046,433 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 15 58,010,162 - 58,044,957 (-) NCBI MGSCv36 mm8 Celera 15 59,700,046 - 59,734,826 (-) NCBI Celera Cytogenetic Map 15 D1 NCBI cM Map 15 24.43 NCBI
Fbxo32 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955540 2,309,315 - 2,340,956 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955540 2,309,315 - 2,334,735 (-) NCBI ChiLan1.0 ChiLan1.0
FBXO32 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 7 140,929,665 - 140,973,569 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 8 116,440,872 - 116,484,172 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 8 120,192,822 - 120,236,116 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 8 122,948,853 - 122,992,157 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 8 122,954,343 - 122,992,157 (-) Ensembl panpan1.1 panPan2
FBXO32 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 13 21,804,442 - 21,838,157 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 13 21,809,292 - 21,838,169 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 13 21,770,175 - 21,803,891 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 13 22,146,431 - 22,178,526 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 13 22,148,672 - 22,178,548 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 13 21,873,240 - 21,906,944 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 13 21,975,418 - 22,009,111 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 13 22,218,984 - 22,252,700 (-) NCBI UU_Cfam_GSD_1.0
Fbxo32 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405303 16,460,677 - 16,496,758 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936470 23,886,970 - 23,918,258 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936470 23,886,836 - 23,919,063 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
FBXO32 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 4 15,895,689 - 15,930,931 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 4 15,895,875 - 15,925,929 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 4 16,639,187 - 16,669,235 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
FBXO32
Fbxo32
.
Predicted Target Of
Count of predictions: 70 Count of miRNA genes: 65 Interacting mature miRNAs: 67 Transcripts: ENSRNOT00000010361 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1300179 Kidm5 Kidney mass QTL 5 3.51 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 7 43747012 135012528 Rat 2293667 Bss42 Bone structure and strength QTL 42 7.25 0.0001 lumbar vertebra size trait (VT:0010518) lumbar vertebra cross-sectional area (CMO:0001689) 7 47651439 92651439 Rat 1331728 Bp214 Blood pressure QTL 214 2.825 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 80221299 124373579 Rat 2317035 Aia16 Adjuvant induced arthritis QTL 16 2.71 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 7 59238038 104238038 Rat 2298475 Eau6 Experimental allergic uveoretinitis QTL 6 0.0029 uvea integrity trait (VT:0010551) experimental autoimmune uveitis score (CMO:0001504) 7 84257275 129257275 Rat 71114 Niddm14 Non-insulin dependent diabetes mellitus QTL 14 4.5 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 7 84257275 129257275 Rat 2293678 Bss24 Bone structure and strength QTL 24 6.71 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 7 47651439 92651439 Rat 1358361 Sradr5 Stress Responsive Adrenal Weight QTL 5 5.55 adrenal gland mass (VT:0010420) both adrenal glands wet weight (CMO:0000164) 7 43747012 108555253 Rat 1357338 Stl17 Serum triglyceride level QTL 17 3.23 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 7 69736356 112729554 Rat 634331 Pia17 Pristane induced arthritis QTL 17 4.7 joint integrity trait (VT:0010548) arthritic paw count (CMO:0001460) 7 73829340 130221005 Rat 1358914 Bp266 Blood pressure QTL 266 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 83591953 134666232 Rat 2293685 Bmd21 Bone mineral density QTL 21 4.2 0.0003 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 7 47651439 92651439 Rat 631504 Cm27 Cardiac mass QTL 27 3.45 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 7 44421311 118198041 Rat 634322 Bw12 Body weight QTL 12 0 body mass (VT:0001259) body weight (CMO:0000012) 7 83153392 128153392 Rat 70173 Niddm19 Non-insulin dependent diabetes mellitus QTL 19 4.33 0.00005 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 7 64002457 135012528 Rat 2317052 Aia17 Adjuvant induced arthritis QTL 17 2.13 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 7 81737938 126737938 Rat 631529 Tls2 T-lymphoma susceptibility QTL 2 0 0.001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 7 80221299 109401111 Rat 2293696 Bmd32 Bone mineral density QTL 32 5.1 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 7 47651439 92651439 Rat 1300151 Bp181 Blood pressure QTL 181 3.36 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 7 53612714 103945643 Rat 1559283 Emca4 Estrogen-induced mammary cancer QTL 4 3.7 mammary gland integrity trait (VT:0010552) percentage of study population developing mammary tumors during a period of time (CMO:0000948) 7 62004452 101773158 Rat 1643004 Pain2 Pain QTL 2 1 mechanical nociception trait (VT:0002734) self mutilation severity score (CMO:0002145) 7 9462246 98011544 Rat 738030 Anxrr8 Anxiety related response QTL 8 4.1 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 7 46590070 91590070 Rat 1300149 Cm6 Cardiac mass QTL 6 4.09 heart mass (VT:0007028) heart left ventricle weight to body weight ratio (CMO:0000530) 7 43747099 102228765 Rat 7411607 Foco15 Food consumption QTL 15 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 7 75918751 120918751 Rat 1558655 Swd4 Spike wave discharge measurement QTL 4 3.68 0.0002 brain electrophysiology trait (VT:0010557) brain spike-and-wave discharge severity grade (CMO:0001988) 7 86983365 131983365 Rat 634336 Anxrr17 Anxiety related response QTL 17 3.66 locomotor behavior trait (VT:0001392) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 7 924703 115097879 Rat 2293707 Bss32 Bone structure and strength QTL 32 7.64 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 7 47651439 92651439 Rat 1331768 Kidm10 Kidney mass QTL 10 4.62096 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 7 80221299 125221299 Rat 61357 Bp38 Blood pressure QTL 38 1.6 0.052 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 41333674 119109060 Rat 1641908 Teswt1 Testicular weight QTL 1 3.28 testis mass (VT:1000644) both testes wet weight (CMO:0000175) 7 80221299 94811326 Rat 2293644 Bmd29 Bone mineral density QTL 29 5.4 0.0001 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 7 47651439 92651439 Rat 2316947 Rf58 Renal function QTL 58 7.8 kidney glomerulus morphology trait (VT:0005325) index of glomerular damage (CMO:0001135) 7 68938720 113886318 Rat 2300178 Bmd54 Bone mineral density QTL 54 5.3 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 7 47651439 92651439 Rat 724537 Niddm52 Non-insulin dependent diabetes mellitus QTL 52 0.02 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 7 80221299 93595843 Rat 1298528 Bp169 Blood pressure QTL 169 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 7 61074194 106074194 Rat 61428 Scl3 Serum cholesterol level QTL 3 3.2 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 7 44867533 89867533 Rat 1331746 Kidm9 Kidney mass QTL 9 3.934 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 7 80221299 112308525 Rat 1576303 Ept7 Estrogen-induced pituitary tumorigenesis QTL 7 3.7 pituitary gland mass (VT:0010496) pituitary gland wet weight (CMO:0000853) 7 62004452 101773158 Rat 7411654 Foco25 Food consumption QTL 25 9.3 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 7 75918751 120918751 Rat 2316955 Stl24 Serum triglyceride level QTL 24 7.1 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 7 68938720 113886318 Rat 2316952 Pur22 Proteinuria QTL 22 5.2 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 7 68938720 113886318 Rat 631540 Bw9 Body weight QTL 9 4.5 body mass (VT:0001259) body weight (CMO:0000012) 7 69736226 117455174 Rat 1358891 Bp265 Blood pressure QTL 265 2.21 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 7 83591953 134666232 Rat
D7Uwm16
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 7 89,740,273 - 89,740,457 (+) MAPPER mRatBN7.2 Rnor_6.0 7 98,074,313 - 98,074,496 NCBI Rnor6.0 Rnor_5.0 7 98,677,793 - 98,677,976 UniSTS Rnor5.0 RGSC_v3.4 7 94,918,218 - 94,918,401 UniSTS RGSC3.4 RGSC_v3.4 7 94,918,217 - 94,918,401 RGD RGSC3.4 RGSC_v3.1 7 94,952,447 - 94,952,631 RGD Celera 7 86,511,895 - 86,512,068 UniSTS Cytogenetic Map 7 q33 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000010361 ⟹ ENSRNOP00000010361
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 7 89,730,232 - 89,765,436 (-) Ensembl Rnor_6.0 Ensembl 7 98,063,735 - 98,098,268 (-) Ensembl
RefSeq Acc Id:
NM_133521 ⟹ NP_598205
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 7 91,620,925 - 91,654,491 (-) NCBI mRatBN7.2 7 89,731,428 - 89,764,997 (-) NCBI Rnor_6.0 7 98,065,664 - 98,098,071 (-) NCBI Rnor_5.0 7 98,669,144 - 98,701,551 (-) NCBI RGSC_v3.4 7 94,909,568 - 94,942,444 (-) RGD Celera 7 86,503,248 - 86,536,357 (-) RGD
Sequence:
ATGCCGTTCCTTGGTCAGGACTGGCGGTCCCCGGGCCAGAGCTGGGTGAAGACGGCGGACGGCTGGAAGCGCTTCTTGGATGAGAAAAGCGGCACCTTCGTGAGCGACCTCAGCAGTTACTGCAACAA
hide sequence
RefSeq Acc Id:
NP_598205 ⟸ NM_133521
- UniProtKB:
Q91Z62 (UniProtKB/Swiss-Prot), G3V6Z4 (UniProtKB/TrEMBL), A6HRK0 (UniProtKB/TrEMBL)
- Sequence:
MPFLGQDWRSPGQSWVKTADGWKRFLDEKSGTFVSDLSSYCNKENLFNSLNYDVAAKKRKKDIQNSKTKTQYFHQEKWIYVHKGSTKERHGYCTLGEAFNRLDFSTAILDSRRFNYVVRLLELIAKSQ
hide sequence
Ensembl Acc Id:
ENSRNOP00000010361 ⟸ ENSRNOT00000010361
RGD ID: 13695348 Promoter ID: EPDNEW_R5872 Type: multiple initiation site Name: Fbxo32_1 Description: F-box protein 32 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 7 98,098,307 - 98,098,367 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2008-02-25
Fbxo32
F-box protein 32
Fbxo32
F-box only protein 32
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2004-02-26
Fbxo32
F-box only protein 32
f-box only protein 32
Symbol and Name status set to approved
625702 APPROVED
2002-08-07
Fbxo32
f-box only protein 32
Symbol and Name status set to provisional
70820 PROVISIONAL
Note Type
Note
Reference
gene_disease
displays increased mRNA expression in denervation, immobilization, and hindlimb suspension models of muscle atrophy
633893
